EuBiologics Co.,Ltd

Related records

Trials (18)

• A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and Older
• A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults
• Age-descending Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Adults and Children
• Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years
• Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults
• Efficacy and Safety of Botulinum Toxin at Moderate to Severe Glabellar Lines
• Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of Oral Cholera Vaccine-Simplified Compared to Shanchol™
• Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants
• Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years
• Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects
• Safety and Immunogenicity of a New Formulation of Euvichol®
• Safety and Immunogenicity of Meningococcal Conjugate Vaccine in Healthy Adults Aged 19 to 55 Years Old
• Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old
• Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults
• Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults
• Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults
• To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine in Healthy Adult Men
• To Evaluate the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children